OBJECTIVE -To estimate the impact of type 1 diabetes during pregnancy on transgenerational genetically caused and/or fuel-mediated amplification of types 1 and 2 diabetes and to estimate the impact of elevated amniotic fluid insulin levels.
T he estimated number of adults with diabetes worldwide in 1995 was 135 million, with 51 million in developed countries. These numbers are estimated to increase to 300 and 72 million, respectively, by 2025 (1) .
A genetically supported mode of transmission is known for type 1 and type 2 diabetes. Additionally, type 2 diabetes can be transmitted from mother to offspring by a nongenetic fuel-mediated mechanism (2, 3) . This is supported by cross-sectional epidemiologic studies showing that individuals with type 2 diabetes are more likely to have a diabetic mother than a diabetic father (4, 5) and by follow-up studies in whites (6) and Pima Indians (7, 8) . Transgenerational transmission of diabetes has also been demonstrated in rats (9) .
Only 2 studies, both from the Diabetes in Pregnancy Center at Northwestern University, have addressed the impact of fetal hyperinsulinism on diabetes-associated problems in adolescents (10, 11) . Both studies found a correlation between elevated amniotic fluid insulin levels and obesity and between the amniotic fluid insulin level and glucose tolerance in offspring of diabetic mothers (10, 11) . These studies did not distinguish between gestational (type 2-like) diabetes and type 1 diabetes. Thus, the genetic divergence makes it difficult to determine whether metabolic impairment in offspring is genetically transmitted or fuel-mediated. In the present study, we examined fuel-mediated transmission of diabetes to offspring of type 1 diabetic mothers, because a genetic predisposition to type 2 diabetes is less likely in this group. Because type 2 diabetes in a white population usually becomes manifest after 20 years of age (12) , we looked for metabolic variations that antedate and are highly predictive of subsequent type 2 diabetes years before the clinical diagnosis (13) . We also looked at the correlation of these data with fetal exposure to insulin in utero, as indicated by the amniotic fluid insulin concentration.
RESEARCH DESIGN AND METHODS

Study subjects and methods
Between 1982 and 1991, 210 viable newborns were delivered of mothers with type 1 diabetes at our institution. We considered the mothers to have type 1 diabetes because they had acute onset of insulin-dependent diabetes at a mean age of 11.6 ± 7.4 years. The mean C-peptide level (136 values in 51 mothers between 5 and 41 weeks' gestation) was 0.3 ± 0.2 ng/ml (0.1 ± 0.07 nmol/l). Moreover, insulin-requiring type 2 diabetes at this age is very rare in our population. All mothers were white. We contacted 136 of the mothers (74 mothers were not trace-
Transgenerational diabetes transmission
able), and a total of 75 offspring of diabetic mothers were available for examination at 5-15 years of age. We contacted the first 12 metabolically healthy mothers (negative oral glucose tolerance test [OGTT]) (14) who delivered at our clinic during the same years to act as control subjects. Of these patients, 49 of 120 were available for examination.
Type 1 diabetic mothers were treated during pregnancy with 3-5 split doses of human insulin, aiming to keep preprandial blood glucose values Ͻ100 mg/dL (5.5 mmol/l) and postprandial levels Ͻ130 mg/dl (7.2 mmol/l) (15) . The mean insulin requirements in the 20th and 38th-40th weeks were 63 and 90 U/24 h, respectively, and the mean maternal blood glucose levels were 100.2 mg/dl (5.5 mmol/l) and 94.0 mg/dl (5.2 mmol/l), respectively. Mean HbA 1c levels decreased from 8% at the onset of pregnancy to 5.1 and 5.0% in the 20th and 38th-40th weeks, respectively (15) . Amniotic fluid insulin levels at 31 ± 2 weeks were available for 59 of the 75 patients (79%) (16) .
Of the 75 type 1 diabetic mothers, 12 (16%) had a family history of maternal or paternal diabetes. Of these 12 mothers' parents, 7 (9.3%) (5 mothers and 2 fathers) had insulin-dependent diabetes at Ͻ20 years of age (probable type 1 diabetes) and 5 (6.7%) (2 mothers and 3 fathers) had manifestation at Ͼ50 years of age and oral or dietary treatment (probable type 2 diabetes). Of the control mothers, 3 (6.1%) of 49 had a maternal history of probable type 2 diabetes.
Height and weight were noted for all offspring to calculate the BMI (kg/m 2 ) and the symmetry index (SI) ([observed weight/ median]/[observed height/median] for age of control subjects) (10, 17) , and pubertal stage was assessed (18) . All offspring underwent an OGTT. Of the offspring of diabetic mothers, 4 had overt diabetes and only 1 of these had an OGTT. Data of overtly diabetic offspring were not included in the metabolic analyses. After an overnight fast, an oral glucose load of 1.75 g/kg (maximum dose 75 g) dissolved in 200 ml of water was administered (11) . Venous plasma was drawn 0, 30, 60, and 120 min after the oral challenge to determine glucose, insulin, and C-peptide levels. Plasma glucose was measured enzymatically with a hexokinase method (Gluco-quant; Boehringer Mannheim, Mannheim, Germany). Plasma samples for insulin and C-peptide measurement were deep-frozen and analyzed at the end of the study. Insulin was measured with a double-antibody radioimmunoassay (Pharmacia RIA 100 Kit; Pharmacia, Uppsala, Sweden) and C-peptide with a competitive protein binding radioimmunoassay (RIA-gnost hC-Peptid; Behring, Marburg, Germany). Cholesterol, HDL, and triglycerides were measured enzymatically in fasting blood samples (test set; Boehringer Mannheim). LDL was calculated from cholesterol and HDL.
In offspring of type 1 diabetic mothers, islet cell antibodies (ICA), GAD antibodies (GADA), and receptor-type protein tyrosine phosphatase antibodies (IA-2A) were measured as markers for type 1 diabetes. ICA were measured by the standard immunofluorescence method using sections of frozen human group 0 pancreas, GADA, and IA-2A with a radiobinding assay. Cutoff for positivity was Ն1 Juvenile Diabetes Foundation ( JDF) units in ICA and Ն0.9 relative units (RUs) in GADA and IA-2A. In the International Diabetes Workshop ICA Proficiency Programs, values of 90-100% for sensitivity and 100% for specificity were achieved. The assays for the detection of GADA and IA-2A were evaluated in the IDW Combined Autoantibody Workshop. The disease sensitivity of the GADA assay was 81%, and the specificity was 99%. The IA-2 antibody assay had a diagnostic sensitivity of 74% and a specificity of 99% (19).
Data were expressed as means with SD or medians with percentiles. Analysis of variance (ANOVA), the Wilcoxon MannWhitney test, the Fisher' s exact test, and the Spearman' s 2-tailed correlation were used as appropriate with Statistical Product and Service Solution software (SPSS, Chicago). Differences were considered statistically significant at P Ͻ 0.05.
RESULTS
Control subjects
Postload glucose, insulin, and C-peptide levels and the I/G quotient in control subjects are shown in Table 1 . There was no correlation between the glucose or lipid levels and age. In contrast, insulin, C-peptide, and I/G quotients correlated at all time points and in sum with age (sum insulin, R = 0.553, P = 0.0001; sum C-peptide, R = 0.595, P = 0.0001; sum I/G quotient I/G, R = 0.593, P = 0.0001). As expected, BMI also increased with age (R = 0.448, P = 0.0014). There were significant differences in glucose-insulin homeostasis between male (n = 20) and female (n = 29) subjects, adjusted for age, height, weight, and BMI. During OGTT, male and female subjects had identical glucose levels at 0 and 120 min, but the glucose peak at 30 min was higher in female subjects (127 ± 20 vs. 114 ± 23 mg/dl, P = 0.036). Insulin levels, C-peptide levels, and I/G quotients were significantly higher in female than in male subjects and most distinct at 60 min after loading (insulin, 27.3 ± 15.7 vs. 48.5 ± 27.4 µU/ml, P = 0.003; Cpeptide, 3.2 ± 1.1 vs. 4.6 ± 1.5 ng/ml, P = 0.002; I/G, 0.262 ± 0.128 vs. 0.454 ± 0.246, P = 0.003).
Control subjects and offspring of diabetic mothers
Maternal demographic data and fetal outcome were similar in offspring of type 1 diabetic mothers and control subjects. There were no differences in maternal age, parity, previous pregnancy losses, height, prepregnancy weight, weight gain during pregnancy, BMI, and macrosomic newborns (20) . Similarly, there were no statistically significant differences in age, pubertal stage, height, weight, or sex in offspring of diabetic mothers and control subjects. The only statistically significant difference was a shorter gestational period in infants of diabetic mothers (Table 2) .
Amniotic fluid insulin was documented at a mean gestational age of 31 ± 2 weeks in 59 of 75 (79%) diabetic mothers. The mean amniotic fluid insulin level was 10.5 ± 7.1 µU/ml (63.0 ± 42.6 pmol/l), the median amniotic fluid insulin 8.2 µU/ml (49.2 pmol/l), and the range 2.0-34.9 µU/ml (12.0-209.4 pmol/l). Only 25 of 59 (42.4%) of amniotic fluid insulin levels were Ͼ10 µU/ml (Ͼ60.0 pmol/l, Ͼ99th percentile of normal) (21) .
Overt diabetes and autoimmune antibodies in offspring Of diabetic mothers, 4 offspring (5.3%, 3 females, 1 male; aged 11.4, 10.7, 9.0, and 15.7 years) had overt diabetes with mani-DIABETES CARE, VOLUME 23, NUMBER 7, JULY 2000 907 Autoimmune antibodies were detected in 16 of 71 offspring without overt diabetes (22.5%, 9 males and 7 females). Of this group, 14 had ICA with a concentration of 1-40 JDF U, 3 had GADA with a concentration of 1.0-47.3 RUs, and 1 offspring had IA-2A (80 RU), ICA (40 JDF U), and GADA (47.3 RU). Glucose tolerance was normal in the 16 offspring with antibodies (Table 3) . Antibody-positive cases had significantly lower mean insulin, C-peptide, and I/G quotients than 55 antibodynegative cases adjusted for demographic and anthropometric factors of mothers and offspring, suggesting onset of impaired ␤-cell function (Table 3) . Offspring with antibodies showed similar metabolic data as control subjects. Antibody-negative offspring differed more distinctly from control subjects than the overall study group (Tables 3 and 4 ). Mean ± SD amniotic fluid insulin levels in antibody-positive and antibody-negative cases were 11.7 ± 9.1 and 10.2 ± 6.4 µU/ml (70 ± 55 and 61 ± 38 pmol/l), respectively (NS).
Weiss and Associates
Comparison of offspring data in control subjects and offspring of type 1 diabetic mothers Offspring of type 1 diabetic mothers had a higher BMI and higher cholesterol, LDL, postload glucose, insulin, and C-peptide levels than control subjects. Insulin resistance (as judged by I/G quotients) was also increased (Table 4) .
When taking the 97th percentile of control subjects as the cutoff (Table 1) , infants of diabetic mothers had a relative risk (RR) of 7.8 for elevated BMI (2.0 vs. 14.1%, P Ͻ 0.03), 5.7 for elevated cholesterol (4.1 vs. 19.7%, P Ͻ 0.02), 4.8 for elevated LDL (4.1 vs. 16.9%, P Ͻ 0.05), 7 for elevated glucose levels 60 min after stimulation (2.0 vs. 12.7%, P Ͻ 0.05), 7.9 for elevated fasting insulin (2.0 vs. 14.1%, P Ͻ 0.03), 6.8 for elevated C-peptide 30 min after stimulation (4.1 vs. 22.5%, P Ͻ 0.01), and 7.9 for elevated I/G quotients in the fasting state (2.0 vs. 14.1%, P Ͻ 0.03).
These metabolic differences between offspring of type 1 diabetic mothers and control subjects were more distinct in male than in female subjects (Fig. 1) . Although glucose levels showed only a statistically significant difference at 30 min after loading, insulin, C-peptide, insulin resistance as judged by the I/G quotient, and the sums of these parameters were significantly elevated at most postload time points (Table 4 and Fig. 1 ).
Amniotic fluid insulin concentration: correlation with metabolic values
After stratification according to high and low amniotic fluid insulin levels (3 values of overtly diabetic offspring were excluded), there was no difference in maternal data and age of the offspring. Lipid levels were similar in offspring of diabetic mothers with low and high amniotic fluid insulin levels. All other metabolic data of offspring with high amniotic fluid insulin levels were elevated, most of them signifi-
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DIABETES CARE, VOLUME 23, NUMBER 7, JULY 2000 cantly so (Table 4) . The RR for an obese offspring was 13 in cases with elevated amniotic fluid insulin levels (odds ratio 23.4, CI 2.8-10.30, P = 0.0004) ( Table 4) . Amniotic fluid insulin concentration correlated with the offspring' s BMI (R = 0.563, P Ͻ 0.001) and SI (R = 0.473, P Ͻ 0.001); postload glucose levels at 60 min (R = 0.315, P = 0.018); insulin levels at 0 (R = 0.289, P = 0.03), 60 (R = 0.395, P = 0.003), and 120 min (R = 0.322, P = 0.016); C-peptide levels at 0 (R = 0.344, P = 0.009), 60 (R = 0.390, P = 0.003), and 120 min (R = 0.416, P = 0.001); and with the I/G quotient at 0 (R = 0.274, P = 0.041), 60 (R = 0.271, P = 0.043), and 120 min (R = 0.356, P = 0.008). Of lipids, only triglycerides correlated with amniotic fluid insulin concentration (R = 0.284, P = 0.034).
Transgenerational diabetes transmission
There was no significant correlation between amniotic fluid insulin concentration and the sum of plasma glucose during OGTT, but there was a correlation with the sums of insulin (R = 0.387, P = 0.003), C-peptide (R = 0.399, P = 0.002), and the I/G quotient in plasma (R = 0.306, P = 0.023).
CONCLUSIONS -This is the first study of the impact of the fetal metabolic experience in utero, as reflected by amniotic fluid insulin levels, on amplification of types 1 and 2 diabetes in offspring of type 1 diabetic mothers.
Offspring of mothers with type 1 diabetes have been reported to have a 1.4-3.2% cumulative inheritance of type 1 diabetes by age 20 (22, 23 ) that increases to 6.3% at 35 years (23). In our series, 4 of 75 (5.3%) infants of type 1 diabetic mothers had overt diabetes at a mean ± SD age of 10.3 ± 2.7 years (range 5-15). In the area of southern Germany bordering Austria, which has a similar population and lifestyle, the population-based prevalence of type 1 diabetes in children aged 0-14 years was 0.074% (24) . Thus, based on our data, the RR for type 1 diabetes in offspring of type 1 diabetic mothers is 71.6.
Autoimmune antibodies are a marker of diabetes manifestation within the next 1-10 years (25) . The predictive power is associated with the level of the antibodies. The risk of overt diabetes increases from 18% at an ICA level of Ն4 JDF U to 44-68% at ICA levels Ն20 JDF U (26, 27) . In the present series, only 1 offspring had an ICA level of 40 JDF U (he also had 47.3 RU GADA and 80 RU IA-2A), and 7 had an ICA level of 3 JDF U and 6 of 1 JDF U. There are too few data in the literature to calculate the risk for diabetes on the basis of these levels. But, antibody-positive subjects in our series had also significantly lower fasting and postload insulin levels than antibody-negative offspring (Table 3) . Although we did not measure antibodies in control subjects, the prevalence of ICA in normal schoolchildren is 1.05% in southern Germany (28) .
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Weiss and Associates Neither overtly diabetic offspring nor nondiabetic antibody-positive offspring showed a trend in amniotic fluid insulin levels. This suggests genetic, rather than fuelmediated, transmission of type 1 diabetes. Why only antibody-negative offspring had metabolic alterations similar to the prediabetic stage of type 2 diabetes is unclear. It is possible that autoimmune antibodies precipitate predominantly in those with genetic predisposition to type 1 diabetes and who, consequently, are less prone to type 2 diabetes and associated risk factors.
Considering the prevalence of antibodies in the nondiabetic offspring of type 1 diabetic mothers in our series and the agerelated increase during the natural history of type 1 diabetes (23), the prevalence of type 1 diabetes in our cohort is likely to approach 8.4% by age 35 years.
Elevated glucose levels, BMI, postprandial and fasting insulin concentrations, and insulin resistance are highly predictive of subsequent type 2 diabetes years before the clinical diagnosis (13, 29, 30) . The natural history seems to be obesity combined with insulin resistance, leading to compensatory hyperinsulinemia to maintain normoglycemia followed by impaired glucose tolerance (IGT). Type 2 diabetes develops when ␤-cells become exhausted or fail to maintain the increased level of insulin secretion (31, 32) .
Elevated BMI, which is an indicator of a network of mutually interrelated functions indicating past insulin resistance, is a significant predictor of diabetes in white Europeans with normal or impaired glucose tolerance (33, 34) . In the present series, the mean BMIs and SIs of infants of type 1 diabetic mothers were significantly higher than those of control subjects and significantly correlated with fasting and postload insulin levels (R = 0.635, P Ͻ 0.001 and R = 0.650-0.497, P Ͻ 0.001, respectively). The RR of an elevated BMI was 13 in offspring with high amniotic fluid insulin levels (Ͼ8 µU/ml, Ͼ48 pmol/l) compared with those at low amniotic fluid insulin levels (Table 4) .
A linear association exists between insulin levels and the incidence of forthcoming IGT and type 2 diabetes (36). Fasting insulin levels and 2-h postload insulin levels in the highest quartile have an RR for an 8-year incidence of type 2 diabetes of 6.6 and 11.6 compared with the remaining 3 quartiles combined (35, 36) . Thus, hyperinsulinemia is the key feature of the susceptibility to type 2 diabetes also underlying other relevant prediabetic disorders (6, 29, 31, 34) .
Because 2-h insulin levels may decrease just before diabetes becomes manifest (33), we estimated the risk for diabetes on the basis of fasting insulin levels. In the present series, 28 of 71 (39.4%) offspring of type 1 diabetic mothers had fasting insulin levels above the highest quartile of control subjects. Considering the predictive power (33), the RR for type 2 diabetes in this series is 2.7 and 3.8 in cases with low and elevated amniotic fluid insulin levels, respectively. Considering the 4.4-4.9% prevalence of type 2 diabetes in those Ͼ30 years of age in Germany (37), the future prevalence of type 2 diabetes in our cohort is estimated as ϳ13 and 18% of the offspring of mothers with low and elevated amniotic fluid insulin levels, respectively.
Subjects with IGT have been reported to have an RR of 5.4 for developing type 2 diabetes within 3 years (33). Silverman et al. (11) found an association between amniotic fluid insulin concentration and IGT in offspring of combined type 1 and gestational diabetic patients. We found a lower proportion of IGT in our series of offspring of type 1 diabetic women than Silverman et al. did in infants of type 1 and gestational diabetic women combined. In the present series, 3 offspring of type 1 diabetic mothers (4%), but none of the control subjects, had IGT, but this difference was not significant. Although the difference may not be statistically significant, IGT is highly unusual in white children of this age (11) .
The lower rate of IGT in our series may be explained by a lower mean age of our children (10.3 vs. 12.3 years). Also, Silverman et al. (11) found a low prevalence of IGT in children Ͻ10 years of age, with a much higher prevalence in those Ն10 years (11) but used a higher amniotic fluid insulin cutoff value (Ͼ16.7 µU/ml, 100 pmol/l) than we did (Ͼ8 µU/ml, Ͼ48 pmol/l).
In the present series, the amniotic fluid insulin concentration correlated with triglycerides; 60-min postload glucose levels; and with postload insulin, C-peptide levels, and the I/G quotients of the offspring. This suggests an influence of fuels on the transmission of the metabolic disturbances known to antedate type 2 diabetes.
In summary, offspring of type 1 diabetic mothers had a much higher rate of type 1 diabetes than control subjects, with a potential of further genetically caused cumulation with increasing age. Additional cumulation is supported by the natural history of diabetes manifestation and by autoimmune antibodies in the absence of diabetes combined with relatively attenuated insulin secretion. On the basis of the literature, the RR of type 1 diabetes was 71.6, and the end point may be calculated as 8.4% by age 35.
Offspring of type 1 diabetic mothers also had a higher incidence of risk factors highly predictive for type 2 diabetes, particularly elevated insulin levels. On the basis of the literature, the estimated RR is 3.2, and the incidence for type 2 diabetes at an age of Ն30 years is ϳ15%.
Diabetes-associated risk factors correlated with the amniotic fluid insulin concentration, whereas no correlation was found with maternal anthropometric factors, family history, or birth weight. Thus, exaggerated type 2 diabetes susceptibility in offspring of type 1 diabetic mothers, judged by diabetes-associated risk factors, is probably fuel-mediated and not genetic. Follow-up of the offspring beyond the age of 30 years will be necessary to prove the calculated diabetes prevalence.
